| http://www.w3.org/ns/prov#value | - In the case of tablets, plasticizers, colorants, pigments, titanium oxide, talc and other additives may also be included. [0039] The present invention also provides enhancers of CYP3A. Examples of the CYP3A enhancers are listed in Table 2, which included, but were not limited to, free bases or the pharmacologically acceptable salts of formononetin, luteolin-7-glycoside and apigenin.
|
